Citicoline and COVID-19: vis-à-vis conjecturedReview Published on 2022-12-012023-07-10 Journal: Naunyn-Schmiedeberg's Archives of Pharmacology [Category] COVID19(2023년), [키워드] citicoline COVID-19 Neuroinflammation SARS-CoV-2. [DOI] 10.1007/s00210-022-02284-6 PMC 바로가기 [Article Type] Review
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case reportCase Reports Published on 2022-12-012023-07-09 Journal: Prion [Category] COVID19(2023년), [키워드] COVID-19 Creutzfeldt-Jakob disease neurodegeneration Neuroinflammation prion protein misfolding. [DOI] 10.1080/19336896.2022.2095185 PMC 바로가기 [Article Type] Case Reports
COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampusArticle Published on 2022-12-012022-11-16 Journal: Apoptosis [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] Alter Analysis Apoptosis assist Brain cause cells Central nervous system changes in Characteristics CNS COVID-19 degeneration demonstrated died distribution Effect glial cell glial cells granular hippocampus histological impairment increase in individual mechanisms memory microglia cells MONITOR Morphological morphological change morphology neurodegenerative disorder Neuroinflammation neurological Neuron neuronal neuronal cell organ oxidative stress recent reduce SARS-COV-2 infection Sholl analysis. the disease tissue sample virus while [DOI] 10.1007/s10495-022-01754-9 PMC 바로가기
Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?Article Published on 2022-11-012022-11-15 Journal: Multiple sclerosis and related disorders [Category] SARS, 진단, [키워드] absence age association case sery cell counts cerebrospinal fluid Characteristics clinical Clinical characteristics CNS Cohort comparable COVID-19 CSF demyelinating Demyelinating disease disease Evidence Follow-up glycoprotein indicate initial lesion magnetic resonance imaging MRI Multiple multiple sclerosis Multiple sclerosis (MS) Myelin Myelin oligodendrocyte glycoprotein antibody-related disease (MOGAD) Neuroinflammation occurred Optical coherence tomography parameter Patient reported SARS-CoV-2 SARS-CoV-2- (COVID-19) vaccination. sclerosis vaccination [DOI] 10.1016/j.msard.2022.104175 PMC 바로가기
SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19Article Published on 2022-11-012022-11-15 Journal: Cell Reports [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] accompanied acute respiratory syndrome astrocytes Brain cellular mechanism CNS coronavirus coronavirus disease COVID-19 CP: Microbiology CP: Neuroscience Diabetic exacerbated High-resolution induce infect Infection initial investigated macaque microglia Microscopy modulated molecular Neuroinflammation Neurological complication Neurological complications Neuron neuronal neurotropism NHP non-human primate model olfactory patients plethora provide reducing Region rhesus rhesus. robust SARS-CoV-2 systemic inflammatory response triggered [DOI] 10.1016/j.celrep.2022.111573 PMC 바로가기
Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive DeclineReview Published on 2022-10-092023-07-11 Journal: Frontiers in bioscience (Elite edition) [Category] COVID19(2023년), [키워드] Alzheimer's disease Anti-inflammatory Anti-oxidant anti-viral phytochemicals ARDS chalcones cognition and memory flavones long COVID disease Neuroinflammation neuroprotection. Nrf2 Parkinson's Disease SARS-CoV-2 [DOI] 10.31083/j.fbe1404027 PMC 바로가기 [Article Type] Review
Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired AdultsArticle Published on 2022-10-042022-11-15 Journal: Neurology [Category] 바이오마커, [키워드] 95% CI accelerate Acidic adjust age Alzheimer disease analyses Analysis association Biomarker Biomarkers change changes Clinical prognosis Clinicians Cohort cortical COVID-19 CSF Disease progression driven by expressed family greater HADS Identifier IL-6 Increased independent interleukin-6 investigated Linear regression model majority marker medication MRI multivariable myeloid cell Neuroinflammation Neuropsychiatric Older pandemic participant Participants pathophysiology performed pet protein levels receptor retrospective risk scale Sex smoking Sociodemographic factor Stress stressors structures subset Symptom tested triggering variable women [DOI] 10.1212/WNL.0000000000200948 PMC 바로가기
Neuroinflammation and COVID-19Review article Published on 2022-10-012022-10-05 Journal: Current Opinion in Neurobiology [Category] COVID19(2023년), SARS, 바이오마커, 치료기술, [키워드] cause caused Central nervous system CNS Combined Coronavirus disease 2019 COVID-19 COVID-19 patients current driving dysregulation Evidence Headaches hemorrhages highlight Immunity immunological mechanism implication Infection Innate immunity Last Mild myeloid cell Neuroinflammation neurological Neurological disease Neurological symptoms pandemic Research Respiratory disease SARS-CoV-2 SARS-COV-2 infection widespread [DOI] 10.1016/j.conb.2022.102608 [Article Type] Review article
Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestationsArticle Published on 2022-10-012022-11-16 Journal: Pathology [Category] COVID19(2023년), SARS, 치료기술, [키워드] Autopsy Brain calculated case sery CD8 Cell Central nervous system clinical clinical manifestation clinical manifestations correlated correlation COVID-19 described Encephalopathy fatal COVID-19 FIVE highest hospitalisation hypoxic IL-6 illness duration intensive care lesion lesions macrophage activation syndrome microglial microthrombi Neuroinflammation neurological Neurological symptoms neuropathology. no correlation one patient onset of symptoms parameter pathology Patient patients performed Pituitary proportion qRT-PCR quantification retrospective SARS-CoV-2 RNA severe COVID-19 patient systemic inflammation T-cell activation Two patient Vascular [DOI] 10.1016/j.pathol.2022.03.006 PMC 바로가기
The nervous system during COVID-19: Caught in the crossfireReview Published on 2022-10-012023-07-09 Journal: Immunological reviews [Category] COVID19(2023년), [키워드] Anosmia COVID-19 NeuroCOVID Neuroimmunology Neuroinflammation olfactory system. SARS-CoV-2 [DOI] 10.1111/imr.13114 PMC 바로가기 [Article Type] Review